D. Babuty

发表

Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1

R. Porcher, A. Lazarus, G. Bassez, 2018, JAMA neurology.

Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.

A. Lazarus, F. Anselme, J. Coste, 2002, Journal of the American College of Cardiology.

First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry.

A. Leenhardt, D. Babuty, N. Delarche, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

C a current-mediated regulation of action potential by pacing rate in rat ventricular myocytes

D. Babuty, J. Fauconnier, S. Richard, 2003 .

Cardiac arrest: it's all in the head

D. Babuty, B. Toffol, Guillaume Breard, 2008, The Lancet.

Carnitine deficiency induces a short QT syndrome.

D. Babuty, J. Le Guennec, J. Thireau, 2016, Heart rhythm.

Fatal QT interval.

D. Babuty, J. Fichet, O. Genée, 2008, The American journal of emergency medicine.

New insights into sexual dimorphism during progression of heart failure and rhythm disorders.

V. Eder, P. Bruneval, D. Babuty, 2010, Endocrinology.

Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD Patients without Pacing Indications

D. Babuty, P. Sick, J. Schwab, 2010, Pacing and clinical electrophysiology : PACE.

Rationale and Design of the OPTION Study: Optimal Antitachycardia Therapy in ICD Patients without Pacing

D. Babuty, P. Sick, R. Ocklenburg, 2010 .

Reply to the Editor-Carnitine and Ventricular Repolarization: A Complex Link?

D. Babuty, J. Le Guennec, J. Thireau, 2016, Heart Rhythm.

Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

D. Babuty, J. Davy, P. Sick, 2014, JACC. Heart failure.

Multitissular involvement in a family with LMNA and EMD mutations

A. Toutain, F. Leturcq, D. Babuty, 2007, Neurology.

A Randomized Study of Defibrillator Lead Implantations in the Right Ventricular Mid‐Septum versus the Apex: The SEPTAL Study τ

J. Daubert, F. Anselme, D. Babuty, 2012, Journal of cardiovascular electrophysiology.

Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2

M. Field, F. Sacher, M. Hocini, 2006, Circulation.

Aborted Sudden Cardiac Death Revealing Isolated Noncompaction of the Left Ventricle in a Patient with Wolff‐Parkinson‐White Syndrome

D. Babuty, J. Fichet, A. Bernard, 2007, Pacing and clinical electrophysiology : PACE.

Are Women with Severely Symptomatic Brugada Syndrome Different from Men?

M. Field, A. Wilde, M. Borggrefe, 2008, Journal of cardiovascular electrophysiology.

The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.

F. Sacher, J. Deharo, A. Leenhardt, 2017, Heart rhythm.

Progressive Cardiac Conduction Defect is the Prevailing Phenotype in Carriers of a Brugada Syndrome SCN5A Mutation

F. Sacher, D. Escande, V. Probst, 2006, Journal of cardiovascular electrophysiology.

Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator – an analysis from the OPTION trial

D. Babuty, J. Davy, P. Sick, 2016, Scientific Reports.

LETTER RESPONSE

D. Babuty, J. Fichet, 2007 .

Sudden cardiac arrest associated with early repolarization.

Thomas Lavergne, Nicolas Derval, Michel Haïssaguerre, 2008, The New England journal of medicine.

Long-Chain Acylcarnitines Regulate the hERG Channel

D. Babuty, P. Fontanaud, J. Le Guennec, 2012, PloS one.

Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

R. Redon, K. Strauch, P. Lambiase, 2022, Nature Genetics.

Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

R. Redon, P. Lambiase, P. Ellinor, 2020, Genetics in medicine : official journal of the American College of Medical Genetics.

Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases

C. Béroud, I. Nelson, A. Toutain, 2015, Journal of neuromuscular diseases.

Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.

R. Redon, F. Sacher, V. Probst, 2017, Heart rhythm.

Clinical Yield of Familial Screening After Sudden Death in Young Subjects: The French Experience

R. Redon, F. Sacher, V. Probst, 2017, Circulation. Arrhythmia and electrophysiology.

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry

M Borggrefe, F Gaita, A A M Wilde, 2010, Circulation.

SCN5A Mutations and the Role of Genetic Background in the Pathophysiology of Brugada Syndrome

A. Wilde, H. Tan, F. Sacher, 2009, Circulation. Cardiovascular genetics.

Clinical Aspects and Prognosis of Brugada Syndrome in Children

A. Wilde, M. Haissaguerre, F. Sacher, 2007, Circulation.

Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.

E. Behr, P. Schwartz, A. Wilde, 2016, Heart rhythm.

Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1

R. Porcher, A. Lazarus, F. Chapon, 2016, European heart journal.

A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial)

Philippe Mabo, J. Daubert, D. Babuty, 2011, European heart journal.

Increased heart rate variability in mice overexpressing the Cu/Zn superoxide dismutase.

Ludovic C. Gillet, C. Andres, D. Babuty, 2008, Free radical biology & medicine.

Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.

D. Babuty, P. Champéroux, S. Judé, 2013, Journal of pharmacological and toxicological methods.

Effect of baroreflex stimulation using phenylephrine injection on ST segment elevation and ventricular arrhythmia-inducibility in Brugada syndrome patients.

F. Sacher, V. Probst, D. Babuty, 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity.

D. Babuty, J. Thireau, F. Aimond, 2012, Cardiovascular research.

The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients.

F. Sacher, V. Probst, D. Babuty, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.

J. Kautzner, F. Sacher, M. Hocini, 2015, Journal of the American College of Cardiology.

Number of electrocardiogram leads in the diagnosis of spontaneous Brugada syndrome.

F. Sacher, V. Probst, D. Babuty, 2019, Archives of cardiovascular diseases.

Clinical presentation and follow-up of women affected by Brugada syndrome.

F. Sacher, V. Probst, D. Babuty, 2019, Heart rhythm.

Value of the sodium-channel blocker challenge in Brugada syndrome.

R. Redon, F. Sacher, V. Probst, 2017, International journal of cardiology.

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.

R. Porcher, É. Marijon, A. Lazarus, 2019, Circulation.

Heart rate variability in mice: a theoretical and practical guide

D. Babuty, J. Thireau, J. Thireau, 2008, Experimental physiology.

Ca2+ current-mediated regulation of action potential by pacing rate in rat ventricular myocytes.

D. Babuty, J. Le Guennec, J. Fauconnier, 2003, Cardiovascular research.

Multicenter study of prophylactic ICD implantation in Brugada syndrome

H. Lemarec, F. Sacher, M. Hocini, 2005 .

β-Adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?

D. Babuty, J. Le Guennec, J. Thireau, 2014, Heart.

An original defibrillation lead implantation to avoid tricuspid prosthesis damage.

D. Babuty, P. Mabo, M. May, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

D. Babuty, J. Davy, P. Sick, 2014, JACC. Heart failure.

The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.

F. Sacher, J. Deharo, A. Leenhardt, 2017, Heart rhythm.